Vitura Health Limited VIT

ASX · Australia · Health Technology

AUD 0.01900.00 (0.00%)

Market open· Oct 2, 2026, 1:13 AM UTC· AUD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Vitura Health Limited VIT

ASX · Australia · Health Technology

AUD 0.01900.00 (0.00%)

Market open· Oct 2, 2026, 1:13 AM UTC· AUD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-50.00% · 6MFull-screen chart

Open AUD 0.0190High AUD 0.0190Low AUD 0.0190Close AUD 0.0190Volume 33.08K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: AUD 0.0190
Day range: AUD 0.0190 – AUD 0.0190
52-week range: AUD 0.0180 – AUD 0.0710
Volume: 33.08K
Market cap: AUD 12.92M
Next earnings date: 2027-03-02
Avg. volume (1Y): 351.48K

Performance

1 week

-9.52%

1 month

-29.63%

3 months

-29.63%

6 months

-52.50%

Year to date

-69.35%

1 year

-71.64%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Country: Australia
Exchange: ASX
Shares outstanding: 662.74M
ISIN: AU0000266801
Beta: -0.54

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMar 23, 2026

Cortexa Advances Commercialisation of MDMA Supply in Australia

MELBOURNE, Australia, March 23, 2026 (GLOBE NEWSWIRE) -- Cortexa (Cortexa or the Company), a leading psychedelic medicines supplier, reaffirms its market leading position in FY2026 for MDMA (3,4-methylenedioxymethamphetamine). Cortexa is a 50/50 joint venture between PharmAla Biotech (CSE: MDMA) and Vitura Health (ASX: VIT). Following completion of the world’s largest (and first Australian) GMP batch of MDMA capsules earlier this financial year, the Company has secured supply arrangements with a

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.